SCHEMBL25502154

SCHEMBL25502154

Cc1ccc(C(=O)N2CCN(c3ccc(C4CCC(=O)NC4=O)cc3)CC2)cc1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.55
▸ CRBN Q96SW2 4/20 0.45
▸ DDB1 Q16531 3/20 0.45
▸ PKM P14618 2/20 0.45
▸ HSD17B10 Q99714 1/20 0.45
▸ ALDH1A1 P00352 4/20 0.44
▸ MAPT P10636 3/20 0.44
▸ MBTD1 Q05BQ5 1/20 0.44
▸ TP53BP1 Q12888 1/20 0.44
▸ L3MBTL4 Q8NA19 1/20 0.44
▸ L3MBTL3 Q96JM7 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ HTT P42858 2/20 0.43
▸ IKZF3 Q9UKT9 1/20 0.43
▸ POLB P06746 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25188462 0.90 HSD17B10 (0.48) LMNACRBNDDB1HSD17B10ALDH1A1
SCHEMBL25502218 0.86 CRBN (0.52) CRBNDDB1HSD17B10ALDH1A1HTT
SCHEMBL25334120 0.83 CRBN (0.55) CRBNDDB1POLB
SCHEMBL30694226 0.82 CRBN (0.51) CRBNDDB1POLB
SCHEMBL31232873 0.80 CRBN (0.52) CRBNDDB1L3MBTL3L3MBTL1POLB
SCHEMBL31232880 0.78 CRBN (0.64) CRBNDDB1MEN1KMT2APOLB
SCHEMBL21876964 0.78 DDB1 (0.67) LMNACRBNDDB1ALDH1A1MAPT
SCHEMBL23301226 0.78 DDB1 (0.67) LMNACRBNDDB1ALDH1A1MAPT
SCHEMBL25026926 0.78 CRBN (0.70) CRBNDDB1POLB
SCHEMBL7828080 0.78 CRBN (0.70) CRBNDDB1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023086399-A1 BIFUNCTIONAL DEGRADERS OF HEMATOPOIETIC PROGENITOR KINASE AND THERAPEUTIC USES THEREOF NURIX THERAPEUTICS, INC. (US) 2023-05-19 — — WO disclosed
Send feedback